Join for free and get access to the buyside
Get insights from the world's most influential hedge fund investors direct to your inbox
- © 2025 Buyside Digest
- Privacy Policy
- Disclaimer
- Sitemap
- Terms of Service
| Quarter | Letter Date | Fund Name | QTD | YTD | Tickers | Keywords/Themes | Theme Commentary | Pitches | Letter |
|---|---|---|---|---|---|---|---|---|---|
| 2025 Q3 | Oct 28, 2025 | Canopy Investors | -4.1% | - | AZO, BVI.PA, EDEN.PA, HEI, MCO.PA, MEDP, ROL, SBAC, STE, SXS.L, TREX, TW | AI, Biotechnology, Construction, Defensive, global, Quality, semiconductors, small caps | The fund underperformed due to a market rotation favoring speculative small caps, but management remains focused on high-quality, cash-generative companies with durable growth profiles. Holdings like Medpace benefited from biotech innovation and clinical research demand, highlighting long-term opportunities in life sciences and industrial technology. The team expects quality small- and mid-cap stocks to regain leadership once speculative excess subsides. | TREX MEDP TREX US MEDP US TREX US MEDP US |
View |
| 2025 Q3 | Oct 16, 2025 | T. Bailey Multi-Asset Growth Fund | 4.0% | - | AAPL, AMZN, AZN.L, CCC.L, COA.L, GOOGL, IMI.L, INTC, ITRK.L, META, MGNS.L, MSFT, MSLH.L, NVDA, ORG.L, ROR.L, STHP.L, SXS.L, TSCO.L, TSLA | AI, diversification, emerging markets, fiscal policy, gold, healthcare, Multi-Asset, risk management | The Polar Capital Healthcare Opportunities fund rebounded sharply after a period of policy-driven pressure, aided by repositioning into lower-cap, lower-regulatory-risk names. Structural tailwindsageing populations, rising healthcare demand, and innovationsupported outperformance. Healthcare remains an attractive long-term theme at discounted valuations with defensible growth. | GLDN AU |
View |
| Date | Pitch Type | Author | Company | Industry | Sub Industry | Bull / Bear | Stock Exchange | Keywords | Action |
|---|---|---|---|---|---|---|---|---|---|
| No pitches found. | |||||||||
| Manager Name | Fund Name | Fund AUM | Invested Value | Portfolio Weight | Shares Owned | Shares Bought / Sold During Quarter | % Bought / Sold During Quarter | % of Shares Outstanding Owned |
|---|---|---|---|---|---|---|---|---|
| No investor data available. | ||||||||